Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2011 (2011), Article ID 438198, 4 pages
http://dx.doi.org/10.4061/2011/438198
Editorial

Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies

1Cardiovascular Research, VA Medical Center, 50 Irving Street NW, Washington, DC 20422, USA
2First Cardiology Clinic, Hippokration Hospital, University of Athens, 114 Vassilissis Sofias Avenue, Athens 11527, Greece
3Division of Cardiology, Temple University School of Medicine; Clinical Campus, Pittsburgh, PA 15232, USA
4Trinity Hypertension Research Institute and Metabolic Research Institute, Punzi Medical Center, Carrollton, TX 75006, USA
5Department of Family and Community Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA

Received 23 March 2011; Accepted 23 March 2011

Copyright © 2011 Vasilios Papademetriou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • Matthew I. Worthley, Costas P. Tsioufis, Ajay Sinhal, Derek P. Chew, Yuvi Malaiapan, Stephen G. Worthley, Ian T. Meredith, and Vasilios Papademetriou, “Safety and efficacy of amulti-electrode renal sympathetic denervation systemin resistant hypertension: the EnligHTN I trial,” European Heart Journal, vol. 34, no. 28, pp. 2132–2140, 2013. View at Publisher · View at Google Scholar
  • Stephen G. Worthley, Gerard T. Wilkins, Mark W. Webster, Joseph K. Montarello, Paul R. Antonis, Robert J. Whitbourn, and Roderic J. Warren, “Safety and performance of the next generation EnligHTN™ renal denervation system in patients with drug-resistant, uncontrolled hypertension: The EnligHTN III first-in-human multicentre study,” Clinical Trials and Regulatory Science in Cardiology, vol. 8, pp. 4–10, 2015. View at Publisher · View at Google Scholar
  • Costas Tsioufis, Vasilios Papademetriou, Kyriakos Dimitriadis, Dimitris Tsiachris, Costas Thomopoulos, Alexandros Kasiakogias, Athanasios Kordalis, Anna Kefala, Evagelia Koutra, Elizabeth Oi-Yan Lau, Guido Grassi, and Christodoulos Stefanadis, “Effects of multielectrode renal denervation on cardiac and neurohumoral adaptations in resistant hypertension with cardiac hypertrophy,” Journal of Hypertension, vol. 33, no. 2, pp. 346–353, 2015. View at Publisher · View at Google Scholar
  • Stephen G. Worthley, Gerard T. Wilkins, Mark W. Webster, Joseph K. Montarello, Sinny Delacroix, Robert J. Whitbourn, and Roderic J. Warren, “Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension,” Atherosclerosis, vol. 262, pp. 94–100, 2017. View at Publisher · View at Google Scholar